TAGecg® Wearable ECG Sensor

Features

  • Small, lightweight, single-lead continuous ECG sensor records for up to 7 days
  • Discrete, wireless & water-resistant—no disruption to patient's daily activities
  • Proprietary algorithm effective in detecting A-Fib and flutter with greater than 98% PPV and sensitivity of 96%1
  • Streamline office workflows with easy application and access to the entire ECG recording
  • Report generated immediately and delivers actionable snapshots of patient data
  • Connect, analyze and interpret results from your office
  • No third-party service or dedicated staff required

Product Specifications

Connects to EMR? No




Top FAQs

View All FAQs

Top Documents

View All Documents

A streamlined path to cardiac diagnostics starts here.

The TAGecg wearable ECG sensor is easy to integrate into your practice—and even easier to use.

Watch this short video to see how simple it can be.

Patient and Physician with TAGecg

One in three patients with A-Fib will have a stroke.2

And with 2.7 million Americans estimated to have A-fib, it is the single most common type of irregular heart rhythm.The TAGecg sensor empowers physicians to detect A-fib and arrhythmia at the point of care with seven-day continuous ECG monitoring in a discrete patch.

 

Good for your patients. Good for your practice.

The TAGecg sensor offers a simple, reimbursable4 test for early A-Fib detection. Learn more about global and individual component CPT® codes for extended continuous ambulatory ECG monitoring.5

TAGecg Reimbursement CPT Codes

 

Start today.

Already purchased the TAGecg sensor and ready to get started? Visit our Setup & Use page for manuals, training videos and much more.

Physician viewing TAGecg data

1 TAGconnect™ Software algorithm accuracy is based on tests conducted on databases available through PhysioNet (https://www.physionet.org/), following guidelines provided by ANSI/AAMI EC57: 2012.

2 Blackshear, Joseph L., MD, “Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation” <http://www.annalsthoracicsurgery.org/article/0003-4975(95)00887-X/pdf>, The Annals of Thoracic Surgery, 1996;61:755-759

3 Barrett, Paddy M et al. Comparison of 24-hour Holter Monitoring with 14-day Novel Adhesive Path Electrocardiographic Monitoring. JACC

4,5 The information contained here is provided for convenience only and represents no statement, promise or guarantee by Welch Allyn concerning coverage or levels of reimbursement. Payment will vary by geographic locality. It is always the provider’s responsibility to determine coding, coverage and claim information for the services that were provided.